Skip to content
Thanks to gene therapies, previously untreatable diseases are now treatable and patient quality of life has improved exponentially. Yet, gene therapy regulatory challenges, along […]
How gene therapy regulatory challenges impact R&D, manufacturing, patients Read More »
Ahead of today’s House Select Committee on the Climate Crisis hearing on food supply chains, BIO submitted comments highlighting the need to incentivize the
Climate change will exacerbate food crisis, says BIO Read More »
According to recent polling data performed by Morning Consult on behalf of the Biotechnology Innovation Organization (BIO), registered voters in five states strongly favor
Voters overwhelmingly support Accelerated Approval, says BIO/Morning Consult poll Read More »
The two-dose Novavax COVID vaccine became the fourth coronavirus vaccine available in the United States after the Food and Drug Administration (FDA) authorized its
FDA authorizes Novavax COVID vaccine for emergency use Read More »
The Senate needs to approve the nominee for Chief Agricultural Negotiator, said the Biotechnology Innovation Organization (BIO) and nearly 100 other organizations in a
Why the USTR urgently needs an agricultural negotiator Read More »
The U.S. Department of Agriculture (USDA) participated in a G20 Meeting of Agricultural Chief Scientists, where it underscored the importance of investing in agriculture
USDA calls for investment in ag and food innovation at G20 meeting Read More »
Last week, the U.S. Food and Drug Administration (FDA) approved Pfizer and BioNTech’s supplemental Biologics License Application (sBLA) for their COVID-19 vaccine, Comirnaty, for
FDA gives full approval to Pfizer-BioNTech COVID vaccine for teenagers Read More »
State-licensed pharmacists in the United States are now authorized to prescribe Pfizer’s COVID-19 pill Paxlovid to eligible patients, with certain limitations to ensure appropriate
Pharmacists authorized to prescribe Paxlovid, FDA says Read More »
Democrats filed a proposal for drug price controls with the Senate Parliamentarian on Wednesday, seeking to classify the bill as “budget reconciliation,” so it
Senate Democrats move forward on drug price controls Read More »
In comments to the U.S. Department of Agriculture (USDA) Animal and Plant Health Inspection Service (APHIS), the biotech sector suggests the agency needs to
BIO: APHIS strategy needs regulatory clarity to boost innovation Read More »
